Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in

Extendicare Inc
OTC:EXETF

Watchlist Manager
Extendicare Inc Logo
Extendicare Inc
OTC:EXETF
Watchlist
Price: 27.66 USD
Market Cap: $2.3B
Write Note Create Alert Ask AI

Wall St Price Targets

EXETF Price Targets Summary
Extendicare Inc

Wall Street analysts forecast EXETF stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EXETF is 26.3 USD with a low forecast of 16.55 USD and a high forecast of 32.52 USD.

EXETF Lowest Forecast
16.55 USD
-40% Downside
EXETF Average Forecast
26.3 USD
-5% Downside
EXETF Highest Forecast
32.52 USD
18% Upside
Lowest Forecast
Price Target
16.55 USD
40% Downside
Average Forecast
Price Target
26.3 USD
5% Downside
Highest Forecast
Price Target
32.52 USD
18% Upside
Extendicare Inc Competitors:
Price Targets
NVT
nVent Electric PLC
17% Upside
NVT
nVent Electric PLC
17% Upside

Revenue
Forecast

-2% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
-2% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 14%.

What are analyst estimates?

Gross Profit
Forecast

-1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-1% / Year
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Extendicare Inc

Operating Income
Forecast

1% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 20%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat
N/A
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
18%
Average Beat

The compound annual growth rate for Net Income over the next 3 years is 19%.

What are analyst estimates?

Continue EXETF Research

Summary
EXETF intrinsic value, competitors valuation, and company profile.
DCF Valuation
EXETF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EXETF stock valuation using valuation multiples.
Wall St Estimates
EXETF price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EXETF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Extendicare Inc listings:
TSX • CAD
EXE
 LSE • CAD
0S9E
 F • EUR
5XE
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EXETF's stock price target?
Price Target
26.3 USD

According to Wall Street analysts, the average 1-year price target for EXETF is 26.3 USD with a low forecast of 16.55 USD and a high forecast of 32.52 USD.

What is the Revenue forecast for Extendicare Inc?
Projected CAGR
14%

Over the last 14 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 14%.

What is the Operating Income forecast for Extendicare Inc?
Projected CAGR
20%

Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 20%.

What is the Net Income forecast for Extendicare Inc?
Projected CAGR
19%

The compound annual growth rate for Net Income over the next 3 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join 349,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett